The spectrum and treatment of gastrointestinal disorders during pregnancy

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 8, 2008, Pages 430-443

  Keller, Jutta ^a   Frederking, Dorothea ^a   Layer, Peter ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; AMINOSALICYLIC ACID DERIVATIVE; ANTACID AGENT; AZATHIOPRINE; BICARBONATE; CIMETIDINE; COLESTYRAMINE; CORTICOSTEROID; ENTECAVIR; ESOMEPRAZOLE; GINGER EXTRACT; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LAMIVUDINE; LANSOPRAZOLE; LAXATIVE; MAGNESIUM SULFATE; MAGNESIUM TRISILICATE; MERCAPTOPURINE; OMEPRAZOLE; PEGINTERFERON; PREDNISOLONE; PROTON PUMP INHIBITOR; RANITIDINE; RIBAVIRIN; SUCRALFATE; THIAMINE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

AUTOIMMUNE HEPATITIS; BLOATING; CHOLECYSTECTOMY; CHRONIC LIVER DISEASE; CLINICAL TRIAL; COLONOSCOPY; CONSTIPATION; DELIVERY; DIET; DISEASE CONTROL; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; ECLAMPSIA; ENTERITIS; FATTY LIVER; GALLBLADDER DISEASE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEARTBURN; HELLP SYNDROME; HEPATITIS A; HEPATITIS B; HEPATITIS C; HIGH FIBER DIET; HUMAN; HYPEREMESIS GRAVIDARUM; INCIDENCE; INTRAHEPATIC CHOLESTASIS; LIFESTYLE MODIFICATION; LIVER TRANSPLANTATION; LOW FAT DIET; NAUSEA AND VOMITING; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; TERATOGENICITY; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

CONSTIPATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER DISEASES; NAUSEA; PREGNANCY; PREGNANCY COMPLICATIONS; VOMITING;

EID: 49249127921     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1197     Document Type: Review

References (85)

1. Mahadevan U and Kane S (2006) American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 131: 283-311
2. Meadows M (online 30 April 2001) [http://www.fda.gov/fdac/features/2001/ 301_page.html#categories] (accessed 3 June 2008)
3. Rey E et al. (2007) Gastroesophageal reflux symptoms during and after pregnancy: A longitudinal study. Am J Gastroenterol 102 2395-2400
4. Bassey OO (1977) Pregnancy heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach. Br J Obstet Gynaecol 84: 439-443
5. Richter JE (2005) Review article: The management of heartburn in pregnancy. Aliment Pharmacol Ther 22: 749-757
6. Van Thiel DH et al. (1977) Heartburn of pregnancy. Gastroenterology 72: 666-668
7. Bor S et al. (2007) Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease. Clin Gastroenterol Hepatol 5: 1035-1039
8. Baron TH (1993) Gastrointestinal motility disorders during pregnancy. Ann Intern Med 118: 366-375
9. Al Amri SM (2002) Twenty-four hour pH monitoring during pregnancy and at postpartum: A preliminary study. Eur J Obstet Gynecol Reprod Biol 102: 127-130
10. Lindow SW et al. (2003) An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy. Int J Clin Pract 57: 175-179
11. H2 bias in their offspring. FASEB J 21: 1264-1270
12. Garbis H et al. (2005) Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol 19 453-458
13. Diav-Citrin O et al. (2005) The safety of proton pump inhibitors in pregnancy: A multicentre prospective controlled study. Aliment Pharmacol Ther 21: 269-275
14. Källén BA (2001) Use of omeprazole during pregnancy - no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 96: 63-68
15. Lalkin A et al. (1998) The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 179: 727-730
16. Koch KL (2002) Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol 186 (Suppl): S198-S203
17. Goodwin TM (2002) Nausea and vomiting of pregnancy: An obstetric syndrome. Am J Obstet Gynecol 186 (Suppl): S184-S189
18. Shah S et al. (2000) Gastrointestinal motility during pregnancy: role of nitrergic component of NANC nerves. Am J Physiol Regul Integr Comp Physiol 279: R1478-R1485
19. Chen Q et al. (1999) Downregulation of Galphaq-11 protein expression in guinea pig antral and colonic circular muscle during pregnancy. Am J Physiol 276: G895-G900
20. Bani D et al. (2002) Relaxin depresses small bowel motility through a nitric oxide-mediated mechanism. Studies in mice. Biol Reprod 66: 778-784
21. Helmreich RJ (2006) Meta-analysis of acustimulation effects on nausea and vomiting in pregnant women. Explore (NY) 2: 412-421
22. 6 for the treatment of nausea and vomiting in pregnancy: A randomised controlled trial. Midwifery (doi:10.1016/j.midw.2007.10.013]
23. Jewell D and Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD000145. [doi:10.1002/14651858.CD000145]
24. Thukral C and Wolf JL (2006) Therapy insight: Drugs fo gastrointestinal disorders in pregnant women. Nat Clin Pract Gastroenterol Hepatol 3: 256-266
25. Markl GE et al. (2007) Prescribing patterns of antiemetic drugs during pregnancy in Germany. Arch Gynecol Obstet 275: 461-467
26. Asker C et al. (2005) Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 61: 899-906
27. Cullen G and O'Donoghue D (2007) Constipation and pregnancy. Best Pract Res Clin Gastroenterol 21: 807-818
28. Bradley CS et al. (2007) Constipation in pregnancy: Prevalence, symptoms, and risk factors. Obstet Gynecol 110: 1351-1357
29. Ponce J et al. (2008) Constipation during pregnancy: A longitudinal survey based on self-reported symptoms and the Rome II criteria. Eur J Gastroenterol Hepatol 20: 56-61
30. Xiao ZL et al. (2005) Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology 128: 667-675
31. Milman N et al. (2006) Side effects of oral iron prophylaxis in pregnancy - myth or reality? Acta Haematol 115: 53-57
32. Jewell DJ and Young G. Interventions for treating constipation in pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD001142 [doi:10.1002/14651858.CD001142]
33. Quartero AO et al. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003460. [doi:10.1002/14651858.CD003460.pub2]
34. Tytgat GN et al. (2003) Contemporary understanding and management of reflux and constipation in the general population and pregnancy: A consensus meeting. Aliment Phamacol Ther 18: 291-301
35. Grossmann EM et al. (2000) Idiopathic megarectum complicating pregnancy: Report of a case. Am J Gastroenterol 95: 2969-2972
36. Cornish J et al. (2007) A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56: 830-837
37. Keller J and Layer P (2002) Effect of chronic inflammatory bowel diseases on fertility and pregnancy [German]. Internist (Berl) 43: 1407-1411
38. Caprilli R et al. (2006) European evidence based consensus on the diagnosis and management of Crohn's disease: Special situations. Gut 55 (Suppl 1): I36-i58
39. Dominitz JA et al. (2002) Outcomes of infants born to mothers with inflammatory bowel disease: A population-based cohort study. Am J Gastroenterol 97: 641-648
40. Katz JA (2002) Endoscopy in the pregnant patient with inflammatory bowel disease. Gastrointest Endosc Clin N Am 12: 635-646
41. O'Mahony S (2007) Endoscopy in pregnancy. Best Pract Res Clin Gastroenterol 21: 893-899
42. Diav-Citrin O et al. (1998) The safety of mesalamine in human pregnancy: A prospective controlled cohort study. Gastroenterology 114: 23-28
43. Park-Wyllie L et al. (2000) Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62: 385-392
44. Gluck PA and Gluck JC (2005) A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 21: 1075-1084
45. Norjavaara E and de Verdier MG (2003) Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide J Allergy Clin Immunol 111: 736-742
46. Polifka JE and Friedman JM (2002) Teratogen update: Azathioprine and 6-mercaptopurine. Teratology 65: 240-261
47. Francella A et al. (2003) The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study. Gastroenterology 124: 9-17
48. Moskovitz DN et al. (2004) The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99: 656-661
49. Norgard B et al. (2007) Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study. Am J Gastroenterol 102: 1406-1413
50. Mahadevan U (2006) Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 55: 1198-1206
51. Katz JA et al. (2004) Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 99: 2385-2392
52. Vasiliauskas EA et al. (2006) Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 4: 1255-1258
53. Oakberg EF et al. (1982) Spermatogenic stage sensitivity to 6-mercaptopurine in the mouse. Mutat Res 94: 165-178
54. Dejaco C et al. (2001) Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 121: 1048-1053
55. Francella A et al. (2003) The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study. Gastroenterology 124: 9-17
56. Norgard B et al. (2004) The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception. Aliment Pharmacol Ther 19: 679-685
57. Mahadevan U et al. (2005) Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 11: 395-399
58. Schutt VA and Minuk GY (2007) Liver diseases unique to pregnancy. Best Pract Res Clin Gastroenterol 21: 771-792
59. Angel García AL (2006) Effect of pregnancy on pre-existing liver disease physiological changes during pregnancy. Ann Hepatol 5 184-186
60. Bacq Y et al. (1996) Liver function tests in normal pregnancy: A prospective study of 103 pregnant women and 103 matched controls. Hepatology 23: 1030-1034
61. Guntupalli SR and Steingrub J (2005) Hepatic disease and pregnancy: An overview of diagnosis and management. Crit Care Med 33 (Suppl S332-S339
62. Arrese M and Reyes H (2006) Intrahepatic cholestasis of pregnancy: A past and present riddle. Ann Hepatol 5: 202-205
63. Keitel V et al. (2006) Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 131: 624-629
64. Reyes H et al. (2006) Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology 43: 715-722
65. Chang CL et al. (2002) Prospective study of liver dysfunction in pregnancy in southwest Wales. Gut 51: 876-880
66. Hay JE (2008) Liver disease in pregnancy. Hepatology 47: 1067-1076
67. Stella CL and Sibai BM (2006) Preeclampsia: Diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 19: 381-386
68. Frishman WH et al. (2005) Pathophysiology and medical management of systemic hypertension in pregnancy. Cardiol Rev 13: 274-284
69. Ibdah JA (2006) Acute fatty liver of pregnancy: An update on pathogenesis and clinical implications. World J Gastroenterol 12: 7397-7404
70. Mihu D et al. (2007) HELLP syndrome - a multisystemic disorder. J Gastrointestin Liver Dis 16: 419-424
71. Martin JN Jr et al. (2006) Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195: 914-934
72. Sharp HT (1994) Gastrointestinal surgical conditions during pregnancy. Clin Obstet Gynecol 37: 306-315
73. Mendez-Sanchez N et al. (2006) Pregnancy and gallbladder disease. Ann Hepatol 5: 227-230
74. Lindseth G and Bird-Baker MY (2004) Risk factors for cholelithiasis in pregnancy. Res Nurs Health 27: 382-391
75. Lu EJ et al. (2004) Medical versus surgical management of biliary tract disease in pregnancy. Am J Surg 188: 755-759
76. Rollins MD et al. (2004) Laparoscopy for appendicitis and cholelithiasis during pregnancy: A new standard of care. Surg Endosc 18: 237-241
77. Sookoian S (2006) Liver disease during pregnancy: Acute viral hepatitis. Ann Hepatol 5: 231-236
78. Kumar A et al. (2004) Hepatitis E in pregnancy. Int J Gynaecol Obstet 85: 240-244
79. Sookoian S (2006) Effect of pregnancy on pre-existing liver disease: chronic viral hepatitis. Ann Hepatol 5: 190-197
80. Buchel E et al. (2002) Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 97: 3160-3165
81. Schramm C et al. (2006) Pregnancy in autoimmune hepatitis: Outcome and risk factors. Am J Gastroenterol 101: 556-560
82. Uribe M et al. (2006) Pregnancy and autoimmune hepatitis. Ann Hepatol 5: 187-189
83. Leuschner U (2005) Autoimmunkrankheiten der Leber und Overlapsyndrome, edn 2 [German]. Bremen: UNI-MED
84. Heathcote EJ (2000) Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31: 1005-1013
85. Manns MP et al. (2006) Treating viral hepatitis C: Efficacy, side effects, and complications. Gut 55: 1350-1359